Ministry of Health Dubai UAE

Under the patronage of H.E. Abdul Rahman Al Owais, UAE Minister of Health, the Medical Practice and License Sector, Drug Registration and Control Department in collaboration with Les Laboratoires Servier is proud to announce:
“3rd National Pharmacovigilance & Risk Management Conference”

under the theme
“New Pharmacovigilance Legislation, Implementation And Risk Management Assessment Industrial Perspective”

The adherence to the pharmacovigilance standards is obligatory for all pharmaceutical industries in UAE.

The main objective of the conference is for the pharmaceutical companies to report ADR & submit their PSUR to the National authority in UAE in order to minimize medication error and adverse drug reactions.

Topics are covered during this conference includes:
• EMA,  new pharmacovigilance legislation, Implementation and Beyond
• Risk Management
• From signal to risk to qualitative benefit-risk evaluation
• PSUR and evaluation of post-authorisation for safety signals
• Qualitative benefit risk assessment methods
• risk minimisation plan , when and measure its effectiveness
• How to write safety evaluation report?
• ICSRs , WHO-ART , CIOMS , MedDRA
• PV in clinical trials , methods and impact
• PV in special products and populations
• Safety requirements for vaccines
• PV audits and inspections
• Work shop session on RISK management assessment
• Industrial experience: Pharmacovigilance System Master File
• Risk management : industrial perspective
• Update of Pharmacovigilance in UAE

Target Audience: 

The program designed for pharmacists as per below categories

A. National Pharmacovigilance Team members
B. Pharmacovigilance officials/coordinators at MoH, medical districts and hospitals
C. Pharmacovigilance officials/coordinators at local health authorities
D. Pharmacovigilance officials/coordinators at other governmental institutions
E. Pharmacovigilance coordinators at private sector
F. Pharmacovigilance officers/coordinators in pharmaceutical companies/Pharma industry
G. Pharmaceutical industries representatives
H. All MoH Pharmacists
I. Clinical pharmacists
J. Hospital pharmacists
K. Pharmacists involved in clinical research and medication safety reporting
L. Post Graduate Pharmacy students
M. Academic faculty at pharmacy colleges in the UAE
N. Community Pharmacists
O. Interested pharmacists

Day 1: Online registration for all below Target Audience categories  A to O

Online registration is open now for limited number of maximum 200 pharmacists only

Day 2: (by invitation and on-site registration For Target Audience categories A to K
 

Professor Saad Shakir

Director of the Drug Safety Research Unit (DSRU) in Southampton , UK

Dr. Shelley Ghandi

ex-MHRA. Director, Pharmacovigilance and Drug Safety at NDA Group AB, United Kingdom

Dr Agnes DEVOIS

Director Division Pharmacovigilance France et Investigation Clinique SERVIER Lieu Région de Paris , France

Dr. Fatima Ali Al Braiki

Director of Drug registration and Control Department in Ministry of Health, UAE.

11 CME Hours: 5 CME Day 1; 6 CME Day 2

MoH CME ID 0310/2013